Neurofibromatosis 2 in the pediatric age group
- PMID: 8355853
- DOI: 10.1227/00006123-199307000-00014
Neurofibromatosis 2 in the pediatric age group
Abstract
Bilateral acoustic neurofibromatosis or neurofibromatosis 2 (NF2) is an autosomal dominant disease predisposing to the formation of multiple tumors in the central and peripheral nervous system. Vestibular schwannomas (VSs) are considered to be the hallmark of the disease, but other tumors and ocular findings occur as well. In patients that do not carry the NF2 mutation, VSs usually occur in the fifth or sixth decade of life. VSs in patients with NF2 are often bilateral and become symptomatic in the third or fourth decade of life. In order to define the early manifestations of NF2, we examined nine children who either had one parent with NF2 or had multiple skin or spinal tumors suggestive of NF2. In addition to neurological, dermatological, and ocular examinations, all patients were studied by gadolinium-enhanced magnetic resonance imaging of the brain and spine. None of the children exhibited symptoms or signs due to VSs. However, VSs were detected during the neuroradiological work-up in six children. Seven children developed symptoms or signs due to skin or spinal tumors. Slit lamp examination detected cataracts in four patients as young as 10 years of age. The diagnosis of NF2 in the pediatric age group requires a high degree of suspicion and should be considered in children with multiple central nervous system or skin tumors without cafe-au-lait spots or Lisch nodules. Because VSs are unlikely to produce the signs seen at the time of admission, careful examination of the skin and eyes is necessary and should be followed by gadolinium-enhanced magnetic resonance imaging of the brain and spine. First-degree relatives need to be examined as well.
Similar articles
-
Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?J Neurosurg. 1998 Jul;89(1):36-41. doi: 10.3171/jns.1998.89.1.0036. J Neurosurg. 1998. PMID: 9647170
-
Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.J Neurosurg Pediatr. 2013 Oct;12(4):317-24. doi: 10.3171/2013.6.PEDS1383. Epub 2013 Aug 2. J Neurosurg Pediatr. 2013. PMID: 23909617
-
Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.J Dermatol. 2007 Jan;34(1):60-4. doi: 10.1111/j.1346-8138.2007.00218.x. J Dermatol. 2007. PMID: 17204104
-
Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.Semin Pediatr Neurol. 2015 Dec;22(4):240-58. doi: 10.1016/j.spen.2015.10.008. Epub 2015 Oct 28. Semin Pediatr Neurol. 2015. PMID: 26706012 Review.
-
The neurofibromatoses. Part 2: NF2 and schwannomatosis.Rev Neurol Dis. 2009 Summer;6(3):E81-6. Rev Neurol Dis. 2009. PMID: 19898272 Review.
Cited by
-
Surgical Management of Sporadic Peripheral Nerve Schwannomas in Adults: Indications and Outcome in a Single Center Cohort.Cancers (Basel). 2021 Mar 1;13(5):1017. doi: 10.3390/cancers13051017. Cancers (Basel). 2021. PMID: 33804463 Free PMC article.
-
Natural history of neurofibromatosis type 2 with onset before the age of 1 year.Neurogenetics. 2013 May;14(2):89-98. doi: 10.1007/s10048-013-0354-0. Epub 2013 Feb 3. Neurogenetics. 2013. PMID: 23377185 Review.
-
Advances in the treatment of neurofibromatosis-associated tumours.Nat Rev Clin Oncol. 2013 Nov;10(11):616-24. doi: 10.1038/nrclinonc.2013.144. Epub 2013 Aug 13. Nat Rev Clin Oncol. 2013. PMID: 23939548 Review.
-
Predictors of the risk of mortality in neurofibromatosis 2.Am J Hum Genet. 2002 Oct;71(4):715-23. doi: 10.1086/342716. Epub 2002 Aug 22. Am J Hum Genet. 2002. PMID: 12235555 Free PMC article.
-
Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.J Neurol Surg B Skull Base. 2021 Jun 8;82(6):643-651. doi: 10.1055/s-0040-1715606. eCollection 2021 Dec. J Neurol Surg B Skull Base. 2021. PMID: 34745832 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous